Menu
 
Research menu
Jump to menu

Publications:  Dr Tatjana Crnogorac-Jurcevic

Crnogorac-Jurcevic T, Radon T, Shah S, Weeks M, Foster J, Sosabowski J, Dumartin L(2019). AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting. Oncotarget
10.18632/oncotarget.26945
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58793
Barry S, Carlsen E, Marques P, Stiles CE, Gadaleta E, Berney DM, Roncaroli F, Chelala C et al.(2019). Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors. Oncogene vol. 38, (27) 5381-5395.
10.1038/s41388-019-0779-5
https://qmro.qmul.ac.uk/xmlui/handle/123456789/57414
Alrawashdeh W, Jones R, Dumartin L, Radon TP, Cutillas PR, Feakins RM, Dmitrovic B, Demir IE et al.(2019). Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling. Mol Oncol vol. 13, (5) 1075-1091.
10.1002/1878-0261.12463
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58937
Gomez-Rubio P, Piñero J, Molina-Montes E, Gutiérrez-Sacristán A, Marquez M, Rava M, Michalski CW, Farré A et al.(2019). Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. Int J Cancer vol. 144, (7) 1540-1549.
10.1002/ijc.31866
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54933
Ntala C, Debernardi S, Feakins RM, Crnogorac-Jurcevic T(2018). Demographic, clinical, and pathological features of early onset pancreatic cancer patients. BMC Gastroenterol vol. 18, (1)
10.1186/s12876-018-0866-z
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54964
Molina-Montes E, Gomez-Rubio P, Márquez M, Rava M, Löhr M, Michalski CW, Molero X, Farré A et al.(2018). Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. Int J Epidemiol vol. 47, (2) 473-483.
10.1093/ije/dyx269
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59043
Lee MH, Thomas JL, Liao CL, Jurcevic S, Crnogorac-Jurcevic T, Lin HY(2018). Epitope recognition of peptide-imprinted polymers for Regenerating protein 1 (REG1). Separation and Purification Technology vol. 192, 213-219.
10.1016/j.seppur.2017.09.071
https://qmro.qmul.ac.uk/xmlui/handle/123456789/44423
CRNOGORAC-JURCEVIC T(2017). Non-invasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine. Gastroenterology
10.1053/j.gastro.2017.09.054
https://qmro.qmul.ac.uk/xmlui/handle/123456789/25665
Marzec J, Dayem Ullah AZ, Pirrò S, Gadaleta E, Crnogorac-Jurcevic T, Lemoine NR, Kocher HM, Chelala C(2017). The Pancreatic Expression Database: 2018 update. Nucleic Acids Res vol. 46, (D1) D1107-D1110.
10.1093/nar/gkx955
https://qmro.qmul.ac.uk/xmlui/handle/123456789/31471
Gomez-Rubio P, Rosato V, Márquez M, Bosetti C, Molina-Montes E, Rava M, Piñero J, Michalski CW et al.(2017). A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk. Ann Oncol vol. 28, (7) 1618-1624.
10.1093/annonc/mdx167
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59040
Wang J, Dumartin L, Mafficini A, Ulug P, Sangaralingam A, Alamiry NA, Radon TP, Salvia R et al.(2017). Splice variants as novel targets in pancreatic ductal adenocarcinoma. Sci Rep vol. 7, (1)
10.1038/s41598-017-03354-z
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24508
Lee M-H, Thomas JL, Liao C-L, Jurcevic S, Crnogorac-Jurcevic T, Lin H-Y(2017). Polymers imprinted with three REG1B peptides for electrochemical determination of Regenerating Protein 1B, a urinary biomarker for pancreatic ductal adenocarcinoma. Microchimica Acta vol. 184, (6) 1773-1780.
10.1007/s00604-017-2169-4
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24507
Gomez-Rubio P, Zock J-P, Rava M, Marquez M, Sharp L, Hidalgo M, Carrato A, Ilzarbe L et al.(2017). Reduced risk of pancreatic cancer associated with asthma and nasal allergies. Gut vol. 66, (2) 314-322.
10.1136/gutjnl-2015-310442
CRNOGORAC-JURCEVIC T, Dumartin L, Alrawashdeh W, Trabulo SM, Radon TP, Steiger K, Feakins RM, di Magliano MP et al.(2016). ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation. Oncogene
10.1038/onc.2016.459
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18288
Cutillas PR, Crnogorac-Jurcevic T(2016). Application of Proteomics in Cancer Biomarker Discovery: GeLC-MS/MS. Methods Mol Biol vol. 1381, 201-209.
10.1007/978-1-4939-3204-7_11
Prica F, Radon T, Cheng Y, Crnogorac-Jurcevic T(2016). The life and works of S100P - from conception to cancer. Am J Cancer Res vol. 6, (2) 562-576.
Radon TP, Massat NJ, Jones R, Alrawashdeh W, Dumartin L, Ennis D, Duffy SW, Kocher HM et al.(2015). Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. Clin Cancer Res vol. 21, (15) 3512-3521.
10.1158/1078-0432.CCR-14-2467
Watt J, Siddique I, Dowe T, Crnogorac-Jurcevic T, Bhattacharya S, Allavena P, Kocher HM (2015). The role of Pentraxin 3 (PTX3) in pancreatic ductal adenocarcinoma. CANCER RESEARCH. vol. 75,
10.1158/1538-7445.PANCA2014-A56
Wong P-P, Demircioglu F, Ghazaly E, Alrawashdeh W, Stratford MRL, Scudamore CL, Cereser B, Crnogorac-Jurcevic T et al.(2015). Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread. Cancer Cell vol. 27, (1) 123-137.
10.1016/j.ccell.2014.10.015
Wong P-P, Demircioglu F, Ghazaly E, Alrawashdeh W, Stratford M, Scudamore C, Cereser B, Crnogorac-Jurcevic T et al. (2015). NOVEL DUAL-ACTION COMBINATION THERAPY ENHANCES ANGIOGENESIS WHILST REDUCING TUMOR GROWTH AND SPREAD. JOURNAL OF VASCULAR RESEARCH. vol. 52, 6-6.
Debernardi S, Massat NJ, Radon TP, Sangaralingam A, Banissi A, Ennis DP, Dowe T, Chelala C et al.(2015). Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma. Am J Cancer Res vol. 5, (11) 3455-3466.
Watt J, Siddiqui I, Radon T, Dowe T, Crnogorac-Jurcevic T, Allavena P, Kocher H (2014). Pentraxin3 Is a Stromal Biomarker in Pancreatic Ductal Adenocarcinoma. GASTROENTEROLOGY. vol. 146, S276-S276.
Watt J, Siddique I, Dowe T, Crnogorac-Jurcevic T, Allavena P, Kocher H(2014). Role of PTX3 in pancreatic cancer. LANCET vol. 383, 106-106.
Haider S, Wang J, Nagano A, Desai A, Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T et al.(2014). A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma. Genome Med vol. 6, (12)
10.1186/s13073-014-0105-3
https://qmro.qmul.ac.uk/xmlui/handle/123456789/6841
Dayem Ullah AZ, Cutts RJ, Ghetia M, Gadaleta E, Hahn SA, Crnogorac-Jurcevic T, Lemoine NR, Chelala C(2014). The pancreatic expression database: recent extensions and updates. Nucleic Acids Res vol. 42, (Database issue) D944-D949.
10.1093/nar/gkt959
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18503
Barry S, Chelala C, Lines K, Sunamura M, Wang A, Marelli-Berg FM, Brennan C, Lemoine NR et al.(2013). S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells. Clin Exp Metastasis vol. 30, (3) 251-264.
10.1007/s10585-012-9532-y
Crnogorac-Jurcevic T, Chelala C, Barry S, Harada T, Bhakta V, Lattimore S, Jurcevic S, Bronner M et al.(2013). Molecular analysis of precursor lesions in familial pancreatic cancer. PLoS One vol. 8, (1)
10.1371/journal.pone.0054830
https://qmro.qmul.ac.uk/xmlui/handle/123456789/4930
Alkhamis T, Barbic J, Crnogorac-Jurcevic T, Greenlaw RE, Peakman M, Jurcevic S(2012). Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice. Clin Exp Immunol vol. 170, (2) 139-148.
10.1111/j.1365-2249.2012.04651.x
Alrawashdeh W, Jones R, Cutillas P, Wijesuriya N, Crnogorac-Jurcevic T(2012). Proteomic Analysis of Perineural Invasion in Pancreatic Adenocarcinoma Reveals Up-Regulation of Neurosecretory Protein VGF in Invaded Nerves. PANCREAS vol. 41, (8) 1346-1346.
CRNOGORAC-JURCEVIC T, LINES KE (2012). S100PBP. Atlas of Genetics and Cytogenetics in Oncology and Haematology
Naidoo K, Jones R, Dmitrovic B, Wijesuriya N, Kocher H, Hart IR, Crnogorac-Jurcevic T(2012). Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases. J Pathol vol. 226, (5) 756-763.
10.1002/path.3959
Lines KE, Chelala C, Dmitrovic B, Wijesuriya N, Kocher HM, Marshall JF, Crnogorac-Jurcevic T(2012). S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells. Am J Pathol vol. 180, (4) 1485-1494.
10.1016/j.ajpath.2011.12.031
Dumartin L, Whiteman HJ, Weeks ME, Hariharan D, Dmitrovic B, Iacobuzio-Donahue CA, Brentnall TA, Bronner MP et al.(2011). AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer Res vol. 71, (22) 7091-7102.
10.1158/0008-5472.CAN-11-1367
Gadaleta E, Cutts RJ, Kelly GP, Crnogorac-Jurcevic T, Kocher HM, Lemoine NR, Chelala C(2011). A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws. Nucleic Acids Res vol. 39, (18) 7900-7907.
10.1093/nar/gkr533
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18659
Tolhurst RS, Thomas RS, Kyle FJ, Patel H, Periyasamy M, Photiou A, Thiruchelvam PTR, Lai C-F et al.(2011). Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth. Breast Cancer Res Treat vol. 128, (2) 357-368.
10.1007/s10549-010-1122-6
Lines KE, Audi N, Chelala C, Wijesuriya N, Kocher H, Hurst H, Crnogorac-Jurcevic T(2011). Role of S100PBP in pancreatic adenocarcinoma. CANCER RESEARCH vol. 71,
10.1158/1538-7445.AM2011-1537
Crnogorac-Jurcevic T, Alrawashdeh W(2011). Biomarker discovery in biological fluids. Sample Preparation in Biological Mass Spectrometry, Editors: Ivanov, AR, Lazarev, A, Springer
Cutts RJ, Gadaleta E, Hahn SA, Crnogorac-Jurcevic T, Lemoine NR, Chelala C(2011). The Pancreatic Expression database: 2011 update. Nucleic Acids Res vol. 39, (Database issue) D1023-D1028.
10.1093/nar/gkq937
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18435
Jiang G, Cao F, Ren G, Gao D, Bhakta V, Zhang Y, Cao H, Dong Z et al.(2010). PRSS3 promotes tumour growth and metastasis of human pancreatic cancer. Gut vol. 59, (11) 1535-1544.
10.1136/gut.2009.200105
Schröder C, Jacob A, Tonack S, Radon TP, Sill M, Zucknick M, Rüffer S, Costello E et al.(2010). Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol Cell Proteomics vol. 9, (6) 1271-1280.
10.1074/mcp.M900419-MCP200
Hariharan D, Weeks ME, Crnogorac-Jurcevic T(2010). Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE). Methods Mol Biol vol. 576, 197-211.
10.1007/978-1-59745-545-9_11
Chelala C, Lemoine NR, Hahn SA, Crnogorac-Jurcevic T(2009). A web-based platform for mining pancreatic expression datasets. Pancreatology vol. 9, (4) 340-343.
10.1159/000212082
Harada T, Chelala C, Crnogorac-Jurcevic T, Lemoine NR(2009). Genome-wide analysis of pancreatic cancer using microarray-based techniques. Pancreatology vol. 9, (1-2) 13-24.
10.1159/000178871
Weeks ME, Hariharan D, Petronijevic L, Radon TR, Whiteman HJ, Kocher HM, Timms JF, Lemoine NR et al.(2008). Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma. PROTEOM CLIN APPL vol. 2, (7-8) 1047-1057.
10.1002/prca.200780164
Barry S, Crnogorac-Jurcevic T (2008). S100P.
Publisher URL
Hariharan D, Crnogorac-Jurcevic T(2008). Expression profiling of chronic pancreatitis. Pancreatitis Research Advances, Nova Publishers Ltd (New York, USA),
Chelala C, Hahn SA, Whiteman HJ, Barry S, Hariharan D, Radon TP, Lemoine NR, Crnogorac-Jurcevic T(2007). Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets. BMC Genomics vol. 8,
10.1186/1471-2164-8-439
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18860
Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T(2007). The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res vol. 67, (18) 8633-8642.
10.1158/0008-5472.CAN-07-0545
Sheikh A, Vimalachandran D, Thompson CC, Jenkins RE, Nedjadi T, Shekouh A, Campbell F, Dodson A et al.(2007). The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer. Proteomics vol. 11, (4) 1929-1940.
10.1097/00006676-200611000-00233
Baril P, Gangeswaran R, Mahon PC, Caulee K, Kocher HM, Harada T, Zhu M, Kalthoff H et al.(2007). Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene vol. 26, (14) 2082-2094.
10.1038/sj.onc.1210009
Neesse A, Gangeswaran R, Luettges J, Feakins R, Weeks ME, Lemoine NR, Crnogorac-Jurcevic T(2007). Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells. Oncogene vol. 26, (11) 1533-1545.
10.1038/sj.onc.1209961
Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, Campbell F, Dodson A et al.(2007). Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut vol. 56, (1) 95-106.
10.1136/gut.2005.083691
Pogue-Geile KL, Chen R, Bronner MP, Crnogorac-Jurcevic T, Moyes KW, Dowen S, Otey CA, Crispin DA et al.(2006). Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med vol. 3, (12)
10.1371/journal.pmed.0030516
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18372
Neesse A, Gangeswaran R, Luettges J, Feakins R, Weeks ME, Lemoine NR, Crnogorac-Jurcevic T(2006). Sperm associated antigen 1 (spag1) is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells. PANCREAS vol. 33, (4) 485-486.
10.1097/00006676-200611000-00166
Capurso G, Lattimore S, Crnogorac-Jurcevic T, Panzuto F, Milione M, Bhakta V, Campanini N, Swift SM et al.(2006). Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Endocr Relat Cancer vol. 13, (2) 541-558.
10.1677/erc.1.01153
Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W et al.(2005). Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology vol. 129, (5) 1454-1463.
10.1053/j.gastro.2005.08.012
Vimalachandran D, Greenhalf W, Thompson C, Lüttges J, Prime W, Campbell F, Dodson A, Watson R et al.(2005). High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res vol. 65, (8) 3218-3225.
10.1158/0008-5472.CAN-04-4311
Akada M, Crnogorac-Jurcevic T, Lattimore S, Mahon P, Lopes R, Sunamura M, Matsuno S, Lemoine NR(2005). Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Clin Cancer Res vol. 11, (8) 3094-3101.
10.1158/1078-0432.CCR-04-1785
Missiaglia E, Donadelli M, Palmieri M, Crnogorac-Jurcevic T, Scarpa A, Lemoine NR(2005). Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway. Oncogene vol. 24, (1) 199-211.
10.1038/sj.onc.1208018
Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, Hansen M, Eloranta JJ, Bhakta V, Brentnall TA, Lüttges J et al.(2005). Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol vol. 166, (1) 81-92.
10.1016/S0002-9440(10)62234-1
Crnogorac-Jurcevic T(2005). Expression profiling in pancreatic cancer using microarray technology. Exocrine pancreas cancer, Editors: Gress, TM, Neoptolemos, JP, Lemoine, NR, Real, FX et al., Solvay Pharmaceuticals
Capurso G, Crnogorac-Jurcevic T, Milione M, Panzuto F, Campanini N, Dowen SE, Di Florio A, Sette C et al.(2005). Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas. Neuroendocrinology vol. 81, (5) 311-321.
10.1159/000088449
Crnogorac-Jurcevic T, Poulsom R, Lemoine NR(2005). The molecular pathology of cancer. Introduction to the Cellular & Molecular Biology of Cancer, Editors: Knowles, M, Selby, P, Edition. 4th, Oxford University Press (Oxford),
Missiaglia E, Blaveri E, Terris B, Wang Y-H, Costello E, Neoptolemos JP, Crnogorac-Jurcevic T, Lemoine NR(2004). Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer vol. 112, (1) 100-112.
10.1002/ijc.20376
Shekouh AR, Thompson CC, Prime W, Campbell F, Hamlett J, Herrington CS, Lemoine NR, Crnogorac-Jurcevic T et al.(2003). Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics vol. 3, (10) 1988-2001.
10.1002/pmic.200300466
Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E, Neoptolemos JP et al.(2003). Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol vol. 201, (1) 63-74.
10.1002/path.1418
Zhu G, Reynolds L, Crnogorac-Jurcevic T, Gillett CE, Dublin EA, Marshall JF, Barnes D, D'Arrigo C et al.(2003). Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer. Oncogene vol. 22, (24) 3742-3748.
10.1038/sj.onc.1206428
Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, Loader J, Terris B, Stamp G, Baron A, Scarpa A et al.(2002). Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene vol. 21, (29) 4587-4594.
10.1038/sj.onc.1205570
Terris B, Blaveri E, Crnogorac-Jurcevic T, Jones M, Missiaglia E, Ruszniewski P, Sauvanet A, Lemoine NR(2002). Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol vol. 160, (5) 1745-1754.
10.1016/S0002-9440(10)61121-2
Fischer C, Bouneau L, Ozouf-Costaz C, Crnogorac-Jurcevic T, Weissenbach J, Bernot A(2002). Conservation of the T-cell receptor alpha/delta linkage in the teleost fish Tetraodon nigroviridis. GENOMICS vol. 79, (2) 241-248.
10.1006/geno.2002.6688
Crnogorac-Jurcevic T, Nielsen TO, Lemoine NR(2002). RT-PCR from laser-capture microdissected samples. Methods Mol Biol vol. 193, 197-204.
10.1385/1-59259-283-X:197
Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B, Jones M, Tyson K et al.(2001). Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene vol. 20, (50) 7437-7446.
10.1038/sj.onc.1204935
Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR, Brentnall TA(2001). Inherited predisposition to pancreatic cancer. Gut vol. 48, (2) 143-147.
10.1136/gut.48.2.143
Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR(2001). Pancreatic cancer genetics. Pancreatology vol. 1, (6) 571-575.
10.1159/000055865
Lemoine NR, Sirivatanauksorn V, CRNOGORAC-JURCEVIC T(2000). Molecular profile of pancreatic cancer. Molecular Pathogenesis of Pancreatic Cancer, vol. 41, IOS Press
Return to top